179 related articles for article (PubMed ID: 4934149)
21. Hybrid resistance to parental NZW bone marrow grafts: association with the D end of H-2.
Lotzová E; Cudkowicz G
Transplantation; 1971 Aug; 12(2):130-8. PubMed ID: 4105763
[No Abstract] [Full Text] [Related]
22. Histoincompatibility between the B10.D2-n and B10.D2-0 strains of mice.
Kaliss N; Bailey DW; Shin HS
Transplantation; 1972 Oct; 14(4):523-5. PubMed ID: 4566169
[No Abstract] [Full Text] [Related]
23. Sex-dependent effects of non-H-2 loci on lethal GVH reaction induced across an H-2 barrier.
Halle-Pannenko O; Mary JY; Motta R
Immunogenetics; 1986; 24(4):217-24. PubMed ID: 3781569
[TBL] [Abstract][Full Text] [Related]
24. Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized.
Murphy WJ; Kumar V; Bennett M
J Exp Med; 1987 Nov; 166(5):1499-509. PubMed ID: 3316472
[TBL] [Abstract][Full Text] [Related]
25. The role of anti-H-2K and H-2D alloantibodies in enhancement and acute antibody-mediated rejection of mouse skin allografts.
de Waal RM; Capel PJ; Koene RA
J Immunol; 1980 Feb; 124(2):719-23. PubMed ID: 6985936
[TBL] [Abstract][Full Text] [Related]
26. Abrogation of hybrid resistance to bone marrow engraftment by graft-vs-host-induced immune deficiency.
Hakim FT; Shearer GM
J Immunol; 1986 Nov; 137(10):3109-16. PubMed ID: 3095424
[TBL] [Abstract][Full Text] [Related]
27. Histocompatibility studies in a closely bred colony of dogs.
Rapaport FT; Watanabe K; Cannon FD; Mollen N; Blumenstock D; Ferrebee JW
J Exp Med; 1972 Nov; 136(5):1080-97. PubMed ID: 4404277
[TBL] [Abstract][Full Text] [Related]
28. Contribution of bone marrow cells and lack of expression of thymocytes in genetic controls of immune responses for two immunopotent regions within poly-(Phe,Glu)-poly-Pro--poly-Lys in inbred mouse strains.
Mozes E; Shearer GM
J Exp Med; 1971 Jul; 134(1):141-61. PubMed ID: 4934146
[TBL] [Abstract][Full Text] [Related]
29. Anti-bacterial immunity to Listeria monocytogenes in allogeneic bone marrow chimera in mice.
Onoé K; Good RA; Yamamoto K
J Immunol; 1986 Jun; 136(11):4264-9. PubMed ID: 2871109
[TBL] [Abstract][Full Text] [Related]
30. H-2-linked genetic control of resistance to histocompatible tumors.
Williams RM; Dorf ME; Benacerraf B
Cancer Res; 1975 Jun; 35(6):1586-90. PubMed ID: 805662
[TBL] [Abstract][Full Text] [Related]
31. Ontogeny of B lymphocytes. 3. H-2 linkage of a gene controlling the rate of appearance of complement receptor lymphocytes.
Gelfand MC; Sachs DH; Lieberman R; Paul WE
J Exp Med; 1974 May; 139(5):1142-53. PubMed ID: 4545163
[TBL] [Abstract][Full Text] [Related]
32. Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans.
Martin PJ
J Exp Med; 1993 Aug; 178(2):703-12. PubMed ID: 8101864
[TBL] [Abstract][Full Text] [Related]
33. Gene complementation. Neither Ir-GLphi gene need be present in the proliferative T cell to generate an immune response to Poly(Glu55Lys36Phe9)n.
Longo DL; Schwartz RH
J Exp Med; 1980 Jun; 151(6):1452-67. PubMed ID: 6770025
[TBL] [Abstract][Full Text] [Related]
34. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
[TBL] [Abstract][Full Text] [Related]
35. Genetic control of bone marrow transplantation in irradiated mice: classification of mouse strains according to their responsiveness to bone marrow allografts and xenografts.
Lotzová E; Dicke KA; Trentin JJ; Gallagher MT
Transplant Proc; 1977 Mar; 9(1):289-92. PubMed ID: 325768
[No Abstract] [Full Text] [Related]
36. Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: long-term survival of allogeneic bone marrow and skin grafts.
Slavin S; Strober S; Fuks Z; Kaplan HS
J Exp Med; 1977 Jul; 146(1):34-48. PubMed ID: 17647
[TBL] [Abstract][Full Text] [Related]
37. Allograft rejection-defined antigens of the B2m,H-3 region.
Graff RJ; Martin-Morgan D; Kurtz ME
J Immunol; 1985 Oct; 135(4):2842-6. PubMed ID: 3928758
[TBL] [Abstract][Full Text] [Related]
38. Identification of a major susceptibility locus for lethal graft-versus-host disease in MHC-matched mice.
Cao TM; Lazzeroni LC; Tsai S; Pang WW; Kao A; Camp NJ; Thomas A; Shizuru JA
J Immunol; 2009 Jul; 183(1):462-9. PubMed ID: 19525392
[TBL] [Abstract][Full Text] [Related]
39. H-2-linked genetic control of murine T-cell-mediated lympholysis to autologous cells modified with low concentrations of trinitrobenzene sulfonate.
Shearer GM; Schmitt-Verhulst AM; Pettinelli CB; Miller MW; Gilheany PE
J Exp Med; 1979 Jun; 149(6):1407-23. PubMed ID: 109569
[TBL] [Abstract][Full Text] [Related]
40. Capacity of genetically different T lymphocytes to induce lethal graft-versus-host disease correlates with their capacity to generate suppression but not with their capacity to generate anti-F1 killer cells. A non-H-2 locus determines the inability to induce lethal graft-versus-host disease.
Van Elven EH; Rolink AG; Veen FV; Gleichmann E
J Exp Med; 1981 Jun; 153(6):1474-88. PubMed ID: 6454750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
